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Neural stem cells (NSCs) from the subventricular zone (SVZ) have been indicated as a
source of new oligodendrocytes to use in regenerative medicine for myelin pathologies.
Indeed, NSCs are multipotent cells that can self-renew and differentiate into all neural cell
types of the central nervous system. In normal conditions, SVZ cells are poorly oligoden-
drogenic, nevertheless their oligodendrogenic potential is boosted following demyelination.
Importantly, progressive restriction into the oligodendrocyte fate is speciﬁed by extrinsic
and intrinsic factors, endocannabinoids being one of these factors. Although a role for
endocannabinoids in oligodendrogenesis has already been foreseen, selective agonists
and antagonists of cannabinoids receptors produce severe adverse side effects. Herein,
we show that hemopressin (Hp), a modulator of CB1 receptors, increased oligodendroglial
differentiation in SVZ neural stem/progenitor cell cultures derived from neonatal mice. The
original results presented in this work suggest that Hp and derivates may be of potential
interest for the development of future strategies to treat demyelinating diseases.
Keywords: oligodendrogenesis, subventricular zone, hemopressin, endocannabinoids, myelin pathologies
OLIGODENDROGENESIS
Oligodendrocytes are the myelin-forming cells of the central
nervous system (CNS) of vertebrates. These glial cells pos-
sess cholesterol-rich membranes that compactly enwrap around
neuronal axons building the so-called myelin sheath. This mul-
tilamellar spiral structure provides an electrical insulation and
clustered distribution of ion channels in nodes and paranodes,
which allows a fast and saltatory propagation of action potentials
along the axon, an essential requirement for normal brain func-
tion. In addition, themyelin sheath sustains and protects the axons
(reviewed in Nave and Trapp, 2008) and oligodendrocytes seem to
play a role in signaling crosstalk with neurons (Bergles et al., 2010).
Oligodendrogenesis actively takes place during CNS devel-
opment and following demyelinating insults, but also more
silently throughout adulthood. Oligodendrocytes differentiate
from oligodendrocyte precursor cells (OPCs), characterized by
the presence of the neuron-glial antigen 2 (NG2) proteoglycan and
therefore often calledNG2 cells (Nishiyama et al., 2009). Forebrain
OPCs are produced in three sequential waves during development,
fromdifferent regions of the ventricular zone (VZ): at early embry-
onic stage (E12.5), from progenitors in the medial ganglionic
eminence (MGE) and the anterior entopeduncular area (AEP);
at E15.5, from progenitors in the lateral and/or caudal ganglionic
eminence (LGE/CGE); and at birth (P0) from progenitors within
the postnatal cortex (Kessaris et al., 2006). The highly prolifera-
tive progenitors migrate from these birth areas and colonize the
developing gray and white matter. Herein, most of them exit the
cell cycle and mature into myelinating oligodendrocytes. Some,
however, remain as slowly dividing OPCs, widespread through-
out the brain parenchyma, and constitute a stable population
that comprises 3–8% of the total number of cells in the adult
brain (Polito and Reynolds, 2005). Genetic fate mapping analysis
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has demonstrated that the progeny of these OPCs is restricted to
the oligodendrocyte lineage, including new myelinating oligoden-
drocytes and further NG2 cells (Dimou et al., 2008; Kang et al.,
2010; Clarke et al., 2012). In addition, the subventricular zone
(SVZ) bordering the lateral ventricles, constitutes a source of few
oligodendrocyte progenitors that migrate and populate the corpus
callosum, striatum and ﬁmbria-fornix in the adult mouse brain
(Menn et al., 2006; Ortega et al., 2013).
Oligodendrogenesis in the adult brain is stimulated by myelin
pathologies. Evidence indicates that most of the remyelinating
oligodendrocytes are derived from the widespread parenchymal
OPCs. Upon a demyelinating injury, these cells are induced to
proliferate and migrate to the demyelinated area, mature and rein-
vest the denuded axons, forming new myelin sheaths (reviewed in
Franklin and ffrench-Constant, 2008). In addition, precursors in
the rodent SVZ niche become activated and contribute to remyeli-
nation of nearby callosal axonal tracts (Nait-Oumesmar et al.,
1999; Picard-Riera et al., 2002; Menn et al., 2006). Noteworthy, an
increased activation of the SVZ niche was detected in post-mortem
samples from multiple sclerosis (MS) patients suggesting that a
similar response may occur in the human brain (Nait-Oumesmar
et al., 2007).
Although robust remyelination upon acute MS lesions results
in functional recovery, as disease progresses, this spontaneous
reparative process starts to fail leading to axonal degeneration
and neurological deﬁcits. In many lesions, remyelination remains
restricted to the edge of the lesion (reviewed in Kotter et al., 2011).
In fact, remyelination in humans varies from patient to patient
or even from lesion to lesion in the same patient. MS lesions are
generally categorized according to the stage of the demyelinating
activity and the presence of immune cells (Frohman et al., 2006);
active demyelinating lesions are characterized by the presence of
myelin-laden macrophages in the lesion or at the edge; smoldering
lesions contain raremyelin-phagocytosingmacrophages at the rim
of the lesion whereas chronic inactive lesions display no evidence
for ongoing demyelination although single T cells may be present
in perivascular regions (Frohman et al., 2006). Recently, several
efforts have been done to understand the causes for remyelination
failure. It has been postulated that in human active lesions (where
remyelination is possible), the density of ﬁbroblast growth factor-2
(FGF-2) expressing macrophages and FGF receptor 1 (FGFR1)-
OPCs increase, whereas the extracellular matrix (ECM) associated
glycoprotein anosmin-1 is absent. In contrast, in chronic-lesions
(where remyelination is mainly restricted to the periplaque),
FGF-2 expression is limited to the macrophages/microglia in the
periplaque, and expression of anosmin-1 is widespread through-
out the core of the lesion and may be preventing remyelination
(Clemente et al., 2011). Multiple causes seem to contribute to the
decline in remyelination, including the failure of OPCs to differ-
entiate and to loop around the nude neuronal axons (Franklin
et al., 2002). Regenerative approaches for demyelinating diseases
have been based on the stimulation of the endogenous self-repair
mechanisms, or on the transplantation of myelinogenic cells, as
for instance derived from neural stem cells (NSCs; Grade et al.,
2013).
NSCs from the SVZ can be highly expanded in culture and
give rise to neurons, astrocytes and oligodendrocytes. Importantly,
SVZ-derived oligodendrocytes undergo all the oligodendrocyte
cell lineage stages from the early bipolar OPC to the mature myeli-
nating oligodendrocyte, recapitulating the developmental process
(Levison and Goldman, 1993; Menn et al., 2006). Furthermore,
these cells are able to remyelinate vulnerable axons when trans-
planted in animal models of demyelinating injuries (Keirstead
et al., 1999; Smith and Blakemore, 2000; Akiyama et al., 2001;
Pluchino et al., 2003; Cayre et al., 2006). However, under nor-
mal conditions, oligodendrocytes represent a small minority of
the SVZ progeny both in vitro and in vivo (Menn et al., 2006).
Excitingly, the last decade has been considerably rich in develop-
ing tools to guide or force cells to acquire a desired fate. Indeed,
pharmacological or genetic tools may be used to direct NSCs to
the oligodendrocyte cell lineage, thus increasing the proportion of
oligodendrocytes in the expanded cultures, prior to transplanta-
tion. On the other hand, the weak endogenous remyelination at
chronic stages of the disease may be assisted by fostering oligo-
dendrocyte differentiation since this constitutes a limiting step for
effective remyelination. Thus, much interest has been gathered on
ﬁnding molecular cues for oligodendrocyte lineage speciﬁcation
and development.
MODULATION OF OLIGODENDROGENESIS
Oligodendrogenesis is regulated by intrinsic and environmental
factors. A reﬁnedknowledge of these factors is necessary in order to
be able tomanipulate oligodendrogenesis for brain repair purposes
in demyelinating diseases.
Importantly, the generation of inducedOPCs (iOPCs) by direct
lineage conversion was recently demonstrated. In fact mouse and
rat ﬁbroblasts can be reprogrammed by forced expression of oligo-
dendrogenic transcription factors into iOPCs with morphologies
and gene expression signatures resembling primary OPCs (Najm
et al., 2013; Yang et al., 2013).
At the levels of gene expression, it has been shown that oligo-
dendrogenesis is modulated by the histone deacetylase sirtuin 1
(SIRT1). Histone acetylation is mainly associated with active gene
transcription. SIRT1 is a member of the sirtuin family and is
expressed in adult mice SVZ and dentate gyrus (DG) in Sox2+
stem cells, proliferating cells and oligodendrocytes but not in
mature astrocytes. Loss of SIRT1 deacetylase activity by condi-
tional ablation of SIRT1 in nestin+ stem cells results in increased
number of oligodendrocyte transcription factor 2 (Olig2)+ OPCs
generated in the SVZ and migrating toward the septum and the
striatum. In fact SIRT1 limits the expression of platelet-derived
growth factor receptor alpha (PDGFRα) in nestin+ stem cells,
involved in proliferation and differentiation of OPCs. Using chro-
matin immunoprecipitation, the authors showed that loss of
SIRT1 increases histone 3 lysine 9 (H3K9) acetylation in the
PDGFRα promoter, therefore allowing its transcription (Rafalski
et al., 2013).
Expression of speciﬁc transcription factors is required to com-
mit cells to the oligodendrocyte lineage. As an example, the
basic-helix-loop-helix transcription factors Olig2 and Mash1 are
key players in determining OPC speciﬁcation. During postnatal
oligodendrogenesis, OPCs double-labeled for Mash1 and Olig2,
are found in the SVZ and corpus callosum. As maturation pro-
ceeds,OPCs express PDGFRα anddown-regulateMash1. Ablation
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of Mash1 during perinatal oligodendrogenesis in mice decreases
the number of mature oligodendrocytes, in the dorsal telen-
cephalon and corpus callosum. In fact, Mash1 regulates the
division of PDGFRα+ OPCs inducing the asymmetric division
of OPCs into one OPC and one oligodendrocyte. In the absence
of Mash1, OPCs divide symmetrically into 2 OPCs decreasing
the generation of future myelinating oligodendrocytes (Nakatani
et al., 2013). During the perinatal period, conditional forced
expression of Olig2 in nestin+ cells of the SVZ increases the
number of OPCs in the SVZ and of mature and myelinating oligo-
dendrocytes in the corpus callosum (Maire et al., 2010). These
data demonstrate that Olig2 expression is crucial for the spec-
iﬁcation of SVZ nestin+ stem cells and OPCs differentiation.
Also, a recent study highlights the importance of Musashi1 func-
tion in oligodendrogenesis. In fact, Musashi1 mRNA binding
protein is expressed in the SVZ stem cells and is required for
the maintenance of the stem cell fate notably by inhibiting the
translation of the Notch inhibitor Numb. Moreover, retroviral-
mediated transduction of Musashi1 in lumbar dorsal funiculus of
mouse pups decreases the proportion of mature oligodendrocytes
(Dobson et al., 2008).
Many soluble factors have been shown to direct oligodendro-
genesis from OPCs and NSCs. For instance, the intracerebroven-
tricular infusion of epidermal growth factor (EGF) increasesOPCs
production in the SVZ,whichmigrate and differentiate intomyeli-
nating oligodendrocytes in the corpus callosum, striatum and
ﬁmbria-fornix (reviewed in Gonzalez-Perez and Alvarez-Buylla,
2011). The pigment epithelium-derived factor (PEDF) is another
pro-oligodendrogenic factor. PEDF is secreted by endothelial cells
and ependymal cells in the SVZ and acts on stem cells to pro-
mote self-renewal (Ramirez-Castillejo et al., 2006). Intracerebral
injection of PEDF increases the number of OPCs in the SVZ
without affecting proliferation, but rather suggesting a role for
PEDF in promoting oligodendroglial speciﬁcation. In fact, PEDF
infusion induces the survival and maturation of local OPCs in
the corpus callosum into myelinating oligodendrocytes. In vitro,
PEDF increases the commitment of glial ﬁbrillary acidic pro-
tein (GFAP)+ stem cells toward the oligodendrocyte lineage by
inducing the expression of transcription factors related to oligo-
dendrogenesis such as Sox10, Olig1 and Olig2 (Sohn et al., 2012).
Similarly, FGF-2 signaling is crucial during the onset of peri-
natal oligodendrogenesis in the SVZ. Intraventricular injection
of FGF-2 increases proliferation and OPCs production in the
SVZ (Azim et al., 2012). Surprisingly conditional inactivation of
FGFR-2 signaling in oligodendrocytes does not affect normal brain
development in mice (Kaga et al., 2006). Nevertheless, FGFR1
and FGFR2 signaling play a role in the speciﬁcation of OPCs
from the embryonic ventral forebrain and regulates myelin sheath
(Furusho et al., 2011, 2012). Also, it has been shown that infusion
of PDGF-AA into the ventricle induces the hyper-proliferation
of NSCs, the so-called type B cells, expanding and producing
hyperplasias of Olig2+ OPCs. Type B cells, but not actively pro-
liferative progenitors (type C cells), express the receptor PDGFRα
and therefore are the cells that originate these glioma-like struc-
tures (Jackson et al., 2006). Intracerebroventricular injection of
the morphogen sonic hedgehog in adult mice brain increases cell
proliferation in the SVZ, septum, striatum and cerebral cortex,
and maturation of oligodendrocytes in the corpus callosum and
cortex (Loulier et al., 2006). The neuroprotective factor thymosin
β4 (Tβ4) present in neurons and microglia induces differentiation
of SVZ into myelinating oligodendrocytes expressing myelin basic
protein (MBP) and 2′,3′-cyclic-nucleotide 3′-phosphodiesterase
(CNPase). Tβ4 inhibits both c-Jun expression and phosphoryla-
tion in SVZ cultures and therefore promotes oligodendrogenesis
as phosphorylated c-Jun binds to myelin genes promoters such as
MBP and CNPase to inhibit their expression (Santra et al., 2012).
The thyroid hormone T3 is also a potent inducer of oligoden-
drocytic differentiation from SVZ cells (Whittemore et al., 1999;
Grade et al., 2010).
TheECMalso regulates oligodendrogenesis. During theperina-
talwave of oligodendrogenesis,OPCs localize close to laminin-rich
basal lamina of vessels in the SVZ. Genetic ablation of laminin
alpha 2 subunit increases cell death of OPCs in the SVZ and in the
corpus callosum during perinatal oligodendrogenesis. Later, by
3 weeks of age, an accumulation of OPCs but fewer mature oligo-
dendrocytes is found and the myelin sheath is thinner. Therefore
laminin is necessary for OPCs survival and maturation of OPCs
into myelinating oligodendrocytes (Relucio et al., 2012). In fact,
oligodendrocytes express a limited repertoire of integrins includ-
ing α6β1, αvβ1, αvβ3, and αvβ5 that are the receptors for ECM
laminin (α6β1), ﬁbronectin and vitronectin. Sequential expression
of these integrins regulates the timing of proliferation, migration
and differentiation during oligodendrogenesis. Oligodendrocyte
O-2A precursor cells are proliferative and migratory bipolar oligo-
dendrocytes expressing α6β1, αvβ1, and αvβ3 integrins. Upon
speciﬁc blocking of αv by Arg–Gly–Asp (RGD) peptides and
anti-β1 antibodies, migration is blocked. During differentiation,
oligodendrocyte precursors lose their ability to migrate which is
correlated to a decrease of αvβ1 integrin expression (Milner and
ffrench-Constant, 1994; Milner et al., 1996). At this step,αvβ3 inte-
grin is transiently expressed and stimulates proliferation before
being down-regulated. Indeed, enhanced proliferation is induced
in CG-4 rat oligodendrocyte cell line engineered to express αvβ3
integrin and plated on vitronectin (and not on poly-D-lysine;
Blaschuk et al., 2000). Then cells exit cell cycle and αvβ5 inte-
grin is up-regulated for terminal differentiation and maturation
(Milner and ffrench-Constant, 1994). In OPCs, integrins regu-
late biological outcomes of PDGF sensing. In fact, association
of PDGFRα to αvβ3 integrin activates the Src kinase Lyn and
triggers proliferation on ﬁbronectin support. However, upon con-
tact with axonal laminin to α6β1, the Src kinase Fyn is activated
and potentiates prosurvival capacities of PDGFRα (Colognato
et al., 2004). Moreover, α6β1 plays a crucial role in oligodendro-
cyte myelination. Numbers of wraps of myelin and amount of
myelin protein MBP at axoglial contacts are dependent of the axon
diameter. It has been shown that laminin substrate induces oligo-
dendrocytes differentiation with increase in processes complexity
and membrane expression of MBP as compared to oligodendro-
cytes plated on poly-D-lysine (Laursen et al., 2011). This effect
is due to translation of MBP mRNA located in the myelinating
nodes. The 3′UTR region of the MBP mRNA contains elements
that repress its translation notably by binding the mRNA binding
protein heterogeneous nuclear ribonucleoprotein-K (hnRNP-K).
In the presence of active α6β1 integrin (through contact with
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axonal laminin), this inhibition is abolished. By immunoprecipi-
tation, it was shown that hnRNP-K interacts with α6β1 integrin in
mature oligodendrocytes cultured on poly-D-lysine and this inter-
action is decreased on laminin substrate. Laursen et al. (2011)
propose that upon activation of integrins, phosphorylation of
hnRNP-K induces the release of MBP mRNA for translation and
myelination.
MODULATION OF OLIGODENDROGENESIS BY
ENDOCANNABINOIDS
Cannabinoids act on at least two types of receptors, type 1 and type
2 cannabinoid receptors (CB1R and CB2R), which are predomi-
nantly distributed in the CNS and immune system, respectively
(Mackie, 2008). Although low levels of CB2R have also been
detected in the CNS (Onaivi et al., 2006). In the brain, CBR
are targeted by endocannabinoids such as anandamide (AEA)
and 2-arachidonylglycerol (2-AG), which are molecules produced
from membrane lipid precursors in response to cell activation,
and therefore a reaction tightly controlled by neuronal activity
(Galve-Roperh et al., 2008). Once generated, endocannabinoids
act retrogradely mainly through presynaptic CB1R, blunting
membrane depolarization and inhibiting neurotransmitter release
(Galve-Roperh et al., 2008).
Interestingly, it was found thatCB1R andCB2R are expressed in
vivo in the SVZ and DG and in nestin+ cells from neural progen-
itor cultures (Jin et al., 2004; Aguado et al., 2005; Arevalo-Martin
et al., 2007; Molina-Holgado et al., 2007). In fact, it was shown that
CB1R and CB2R activation promotes NSC proliferation both in
the hippocampus and SVZ (Jin et al., 2004; Aguado et al., 2005;
Palazuelos et al., 2006; Molina-Holgado et al., 2007; Goncalves
et al., 2008; Xapelli et al., 2013). Moreover, endocannabinoids have
emerged as a potential target to modulate oligodendrogenesis, by
modulating CB1R and CB2R. In fact, Arevalo-Martin et al. (2007)
have found that postnatal treatmentwith aCB1R agonist increased
the number of Olig2+ cells in the rat SVZ. Furthermore, recent
studies suggest that endocannabinoids play a role in oligoden-
drocytic differentiation (Gomez et al., 2010; Solbrig et al., 2010;
Gomez et al., 2011) and might modulate several neurodegenera-
tive diseases (reviewed in Velayudhan et al., 2013). Very recently it
was shown thatCB1Ractivationpromoteddifferentiationof OPCs
and improved remyelination after stroke-induced demyelination
(Sun et al., 2013). Despite the role of endocannabinoid receptors
in several pathologies, selective agonists and antagonists produce
severe adverse side effects. Indeed, activation of CB1 and/or CB2
receptor leads to increased psychoactivity, cardiovascular prob-
lems, obesity, diabetes, and inﬂammation (reviewed in Pacher and
Kunos, 2013).
Hence it is of great importance to ﬁnd alternative new drugs
able to modulate cannabinoid receptors. Recent ﬁndings suggest
that hemopressin (Hp), a nine residue-long peptide derived from
the hemoglobin (Hg), modulates the cannabinoid receptors activ-
ity (Heimann et al., 2007; Gomes et al., 2010; Bomar and Galande,
2013). In fact, it was shown that Hp acts as a CB1R inverse
agonist in vivo and inhibits appetite and induces antinocicep-
tion (Heimann et al., 2007; Dodd et al., 2010) and importantly
it was suggested that Hp exerts its effects by an alternative mode of
action which might avoid adverse side effects (Dodd et al., 2013).
Therefore, we investigated the role of Hp in SVZ oligodendro-
genesis and found that this peptide promotes oligodendrocytic
differentiation and maturation.
MATERIAL, METHODS AND RESULTS
All experiments were performed in accordance with the European
Community guidelines for the care and use of laboratory animals
(86/609/EEC; 2010/63/EU).
We have used SVZ neurospheres prepared from early postnatal
(P1-3) C57BL/6mice in serum-freemedium (SFM) supplemented
with 10 ng/ml EGF and 5 ng/ml FGF-2 (both from Invitrogen,
Carlsbad, CA, USA), as described previously (Xapelli et al., 2013).
SVZneurosphereswere seeded for 48 h onto glass coverslips coated
with 0.1 mg/ml poly-D-lysine in SFM medium devoid of growth
factors. To evaluate cell death/proliferation or oligodendrocytic
differentiation, the neurospheres were allowed to develop for fur-
ther 2, 4, and 7 days at 37◦C in the absence or presence of Hp
(100 nM or 1 μM; Proteimax, São Paulo, SP, Brazil; Figures 1A
and 2A).
First we investigated whether Hp modiﬁed cell apoptosis,
which was evaluated by the terminal deoxynucleotidyl transferase
dUTP nick-end labeling (TUNEL) assay. SVZ plated neurospheres
treated with Hp (100 nM or 1 μM) for 48 h (Figure 1A) were
ﬁxed in 4% paraformaldehyde (PFA) and reacted with the ter-
minal deoxynucleotidyl transferase according to manufacturer’s
instructions (Roche, Basel, Switzerland). Apoptotic nuclei were
labeled with ﬂuorescein followed by nuclei counterstaining with
Hoechst 33342 (all from Invitrogen). Finally, the preparations
weremountedusingDakocytomationﬂuorescentmedium(Dako-
cytomation, Carpinteria, CA, USA). We observed no signiﬁcant
differences in the percentage of TUNEL+ nuclei between control
and Hp-treated cultures, indicating that Hp was not toxic to the
cells (Control: 11.38 ± 1.15%, Hp 100 nM: 10.26 ± 1.70%, Hp
1 μM: 13.25 ± 1.56%; n = 3; Figures 1B,C).
To investigate the effect of Hp on cell proliferation, SVZ cells
were exposed to 10 μM 5-bromo-2’-deoxyuridine (BrdU; Sigma-
Aldrich), for the last 4 h of each Hp (100 nM or 1 μM) treatment
(48 h). Then, SVZ cells were ﬁxed in PFA and BrdU was immuno-
labeled with the anti-BrdU mouse monoclonal antibody (Clone
MoBU-1) Alexa Fluor 594 (Invitrogen) as described previously
(Xapelli et al., 2013; Figure 1A). We have found that Hp did
not induce proliferation since the percentage of BrdU+ cells in
Hp treated cultures were similar to control conditions (Control:
4.38 ± 0.21%,Hp 100 nM: 4.01 ± 0.81%,Hp 1 μM: 4.70 ± 0.53%;
n = 2; Figures 1D,E).
Hp effect on oligodendroglial differentiation was investigated
by incubating SVZ neurospheres for 2, 4, or 7 days with Hp
(1 μM; Figure 2A) and western blotting analysis of oligodendro-
cyte markers at different stages of differentiation was performed:
Olig2 (present during all oligodendrocyte development), PDGFRα
(marker of OPC or pre-oligodendrocyte), Galactosylceramidase
(GalC, pre-myelinating oligodendrocyte) and proteolipid protein
(PLP, myelinating oligodendrocyte). Moreover, an immunocyto-
chemistry for PDGFRα, GalC and PLP was performed following 2,
4, and 7 days of Hp treatment, respectively with the primary anti-
bodies listed in Table 1 and using a protocol described previously
(Xapelli et al., 2013).
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FIGURE 1 | Hp did not induce cell death nor cell proliferation.
(A) Experimental protocol. (B) Representative ﬂuorescence digital images of
SVZ cell cultures treated for 48 h in the absence (control) or presence of Hp
(1 μM) and stained using theTUNEL (Terminal deoxynucleotidyl transferase
dUTP nick end labeling) method to reveal apoptotic nuclei (in green) and
Hoechst 33342 (blue nuclei). (C) Bar graph depicts the percentages of
TUNEL-stained nuclei. (D) Representative ﬂuorescence digital images of SVZ
cell cultures in the absence (control) or presence of Hp (1 μM) and
immunolabeled for BrdU (5-bromo-2′-deoxyuridine, red nuclei) and Hoechst
33342 (blue nuclei). (E) Bar graph depicts the percentages of
BrdU-immunostained nuclei. Data are expressed as a mean ± SEM of 2–3
independent experiments. Scale bar: 50 μm.
We have observed that although most of protein levels did not
changewhen comparingwith the respective control at the different
time-points (Figure 2B), the morphology was very different in the
cultures that were treated with Hp 1 μM (Figure 2E). In fact,
PDGFRα and GalC immunoreactivity was increased following Hp
treatment for 2 and 4 days respectively (Figure 2E). Interestingly,
after 7 days of Hp incubation PLP-protein levels increased (to
165.3 ± 47.77% when compared with 100% Control 7 days, n = 4,
P< 0.05; Figure 2B). Moreover, we observed that oligodendrocyte
maturation was promoted upon Hp treatment for 7 days since the
number of PLP+ cells increased when compared with control
cultures (Control: 100 ± 0.00%, Hp 1 μM: 314.40 ± 76.06%;
n = 4, P < 0.05; Figures 2C–E).
Functional oligodendroglial differentiation was evaluated by
single cell calcium imaging (SCCI) to analyze the intracellu-
lar variations of calcium-free levels ([Ca2+]i) in single cells
following stimulation with 50 mM KCl, 100 μM histamine
(Sigma-Aldrich) and 0.1 U/ml thrombin (Sigma-Aldrich) as pre-
viously described (Grade et al., 2010). Brieﬂy, SVZ cultures were
loaded with Fura-2/AM, then were continuously perfused with
Krebs solution (132 mM NaCl, 4 mM KCl, 1.4 mM MgCl2,
1 mM CaCl2, 6 mM glucose, 10 mM HEPES, pH 7.4) and
Frontiers in Cellular Neuroscience www.frontiersin.org February 2014 | Volume 8 | Article 59 | 5
Xapelli et al. Hemopressin promotes SVZ oligodendrogenesis
FIGURE 2 | Hp induced oligodendroglial differentiation in SVZ cultures.
(A) Experimental protocol. (B) Bar graphs of oligodendrocyte transcription
factor 2 (Olig2), Platelet-derived growth factor receptor alpha (PDGFRα),
Galactosylceramidase (GalC) and Proteolipid Protein (PLP) protein levels of
control and Hp 1 μM treated cultures for 2, 4, and 7 days. Data are expressed
as mean ± SEM of 4–7 independent experiments. *P < 0.05; using
Bonferroni’s multiple comparison test for comparison with the respective
control culture. (C) Representative ﬂuorescence digital images of PLP+
oligodendrocytes (in green) and Hoechst 33342 staining (blue nuclei) in SVZ
cultures. Scale bar: 50 μm. (D) Bar graph depicts the number of PLP+ cells,
expressed as the total number of cells counted per culture, in control and Hp
(1 μM) treated cultures for 7 days. Data are expressed as mean ± SEM of
4 independent experiments. *P < 0.05 using using unpaired student’s t -test
for comparison with control culture. (E) Representative confocal digital
images of PDGFRα, GalC and PLP in control cultures and in cultures treated
with Hp 1 μM for 2, 4, and 7 days of differentiation, respectively. PDGFRα (in
red); GalC (in red), PLP (in green), and Hoechst 33342 (used to visualize cell
nuclei, in blue). Scale bars = 50 μm. Squares are plans of higher
magniﬁcations. Scale bars = 20 μm. (F): Representative single cell calcium
imaging (SCCI) proﬁles of response of 8–10 cells in a control culture (no drug
exposure) and, in a culture treated with Hp (1 μM) for 7 days. (G) Bar graph
depicts the percentages of oligodendroglial-like responding cells in SVZ
control cultures and in cultures exposed to Hp (100 nm and 1 μM). Data are
expressed as mean ± SEM of 4–7 independent experiments. **P < 0.01;
using Dunnett’s multiple comparison test for comparison with SVZ control
cultures.
stimulated with KCl, histamine and thrombin. [Ca2+]i varia-
tions were evaluated by quantifying the ratio of the ﬂuorescence
emitted at 510 nm following excitation at 340 and 380 nm.
KCl, histamine, and thrombin peaks given by the normalized
Table 1 | Primary antibodies used for immunocytochemistry.
Antigen Company Host Dilution
PDGFRα BD Biosciences, San Diego, CA, USA Rat 1:500
GalC Millipore Mouse 1:500
PLP AbD Serotec, Kidlington, UK Mouse 1:1000
ratios of ﬂuorescence at 340/380 nm, were used to calculate
the ratios of the responses to thrombin/histamine, as it was
previously shown that ratios above 1.3 are consistent with oligo-
dendroglial differentiation in SVZ cultures (Grade et al., 2010).
Indeed it was shown that cells that increased their calcium levels
speciﬁcally following thrombin stimulation are immunoreactive
for O4 and PLP; and oligodendrocytes progenitors expressing
the proteoglycan NG2 are responsive to thrombin (lesser than
mature oligodendrocytes) but also to histamine consistent with a
transition state between immature precursor and mature oligo-
dendrocytes (Grade et al., 2010). In fact, Hp treatment increased
the percentage of oligodendrocyte-like cells in SVZ cell cultures
(Control: 1.83 ± 0.73%, Hp 100 nM: 15.84 ± 3.85%, Hp 1 μM:
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12.44 ± 3.76%; n = 4, P < 0.01; Figures 2F,G). Moreover, using
single cell imaging, we quantiﬁed the number of cells displaying
a KCl/Histamine ratio of response inferior to 0.8 (consistent with
mature neurons), and a ratio between 0.9 and 1 (consistent with
mature GFAP+ astrocytes; Agasse et al., 2008). We found that
Hp at 1 μM for 7 days increase neuronal differentiation (Con-
trol: 11.65 ± 1.58%; Hp 100 nM: 22.68 ± 7.99%; Hp 1 μM:
22.52 ± 5.68%; n = 6, P < 0.05), without altering the num-
ber of GFAP-positive astrocytes (Control: 40.01 ± 3.39%; Hp
100 nM: 34.40 ± 4.64 %; Hp 1 μM: 33.73 ± 3.32; n = 6; data
not shown).
FUTURE DIRECTIONS
Due to the adverse side effects of synthetic cannabinoid ago-
nists and antagonists (reviewed in Pacher and Kunos, 2013) it
is very important to ﬁnd other selective modulators that maintain
therapeutic properties without producing side effects. Therefore,
Hp, as a peptide modulator of the cannabinoid receptor, may
be a potential therapeutic agent. In fact, it was shown that Hp
inhibits appetite and induces antinociception without causing
motor abnormalities or sedative effect (Heimannet al., 2007;Dodd
et al., 2010, 2013).
Here we have observed that Hp treatment did not affect cell
death and proliferation, but promoted oligodendrocytic differen-
tiation and maturation of SVZ stem/progenitor cells. In light of
these evidences, Hp and its derivates might be useful in future
strategies to treat or prevent demyelinating disorders. Therefore,
following steps urge at studying the effect of Hp in animal models
of demyelinating diseases, from oligodendrocytic differentiation
in vivo to amelioration of the disease symptoms.
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